SIGNAL // LOADING
Loading page
Weight Management
Provider ReviewedSemaglutide Injectable
The GLP-1 with ~14.9% mean weight loss at 68 weeks in STEP-1. Cleared through labs, intake, and provider review, paired with coaching that keeps it working past week four.
Subscribe & Save
Easy to cancel anytime
$299/mo
One Time Purchase
Available after provider review
$299
Nothing ships until intake clears a licensed provider. If the pathway isn't right, we say so.
Key Benefits
- ~14.9% average weight loss at 68 weeks (STEP-1)
- ~1.5-1.8% HbA1c reduction at max dose (SUSTAIN)
- 5-step titration with coaching dedicated to weeks 1-4
- Fiber, protein, and motility plan bundled with the Rx
Clinical Rationale
Semaglutide is a GLP-1 receptor agonist. STEP-1 showed ~14.9% mean weight loss at 68 weeks on 2.4 mg weekly versus ~2.4% on placebo. SUSTAIN trials show 1.5-1.8% HbA1c reduction at max dose in T2D. Eligibility is thyroid history, pancreatitis status, pregnancy, and interactions with current Rx. Every intake clears a licensed provider before dispensing.
DirectionsBegin with assessment and provider review. Treatment, dosing, and follow-up are determined by clinical eligibility.
Safety Notes
Prescription products require clinical eligibility and provider approval.
Medication availability varies by state and clinical criteria.
Fit check
Who this is for - and who it isn't
Who this is for
- BMI 30+, or 27+ with metabolic comorbidity (HbA1c 5.7-6.4%, hypertension, dyslipidemia)
- Prior tolerance to a GLP-1 - semaglutide is the right re-entry for members who did well on Wegovy or Ozempic
- Insurance coverage that lands on Wegovy/Ozempic rather than Zepbound
Who this isn't for
- Personal or family history of medullary thyroid carcinoma or MEN2
- Active pancreatitis, gastroparesis, or recent bariatric surgery
- Pregnancy, breastfeeding, or actively trying to conceive
- Short-term cosmetic cuts - the 3-6 month arc is where the data lives
Using it well
How to combine and what to watch for
How to combine
- Fiber and 2.5-3.5 L water daily from week 1 to hold motility through titration
- Protein at 0.7-1.0 g per lb lean mass, plus creatine at 3-5 g/day
- Retest HbA1c, lipid panel, and liver function every 3-6 months on therapy
Safety considerations
- Slow titration is the single biggest lever on GI tolerance
- Breastfeeding guidance varies - raise it with your provider before refilling
- Escalate immediately for severe abdominal pain, uncontrolled vomiting, or gallbladder symptoms
Quality Standards
Third-party tested where applicable. Every regulated Rx clears licensed provider review under state rules - no exceptions.
What membership unlocks
- + Provider-led decisions
- + Coaching
- + Follow-up tasks
- + Lab-informed adjustments
Run the labs first
Most protocols perform better when the baseline is measured before you start. Add ApoB, HbA1c, fasting insulin, and the hormones that matter for your goal.
See lab packagesGenerative engine summary
Semaglutide Injectable in three clean lines.
- Semaglutide Injectable sits inside ALUKARD's weight management path and is built to pair with labs or provider-reviewed care when the goal calls for it.
- Regulated. Every script clears intake, eligibility, and licensed-provider review - no same-day approvals.
- Semaglutide is a GLP-1 receptor agonist. STEP-1 showed ~14.9% mean weight loss at 68 weeks on 2.4 mg weekly versus ~2.4% on placebo. SUSTAIN trials show 1.5-1.8% HbA1c reduction at max dose in T2D. Eligibility is thyroid history, pancreatitis status, pregnancy, and interactions with current Rx. Every intake clears a licensed provider before dispensing.
Where we ship
Semaglutide Injectable is gated by state licensure and pharmacy access. Confirm eligibility in your state before you book the assessment.
Related Guides
Deeper reads on Semaglutide Injectable.
7 min read
GLP-1 eligibility explained: who qualifies, who doesn't, and why
Most telehealth sites approve nearly every intake that clicks through. We don't. About one in five GLP-1 intakes gets routed elsewhere - thy...
6 min read
Tirzepatide vs semaglutide: how to think about the choice
They share a class name, not a receptor profile. Tirzepatide delivers ~6 percentage points more average weight loss than semaglutide in pivo...
6 min read
GLP-1 side effects: what's normal, what needs review, what stops the protocol
Most GLP-1 side effects are titration-related and resolve in 1-2 weeks at each dose step. A small number are red flags that need a same-day ...
Related Glossary
The terms Semaglutide Injectable runs into.
Questions
Before you start, the questions we actually get.
What happens after assessment?
A licensed provider reviews your intake and labs. If semaglutide is a fit, they set titration and follow-up. If not, they route you to the right pathway - decline is a real outcome.
Semaglutide or tirzepatide?
Tirzepatide has higher average weight loss; semaglutide has the longer post-market safety tail and clearer insurance pathways. See the compare guide for the full decision.
Is compounded semaglutide the same as Ozempic?
No - compounded is not FDA-reviewed for efficacy and availability varies by state. We disclose sourcing upfront so you know exactly what you're taking.
Can I switch between GLP-1s mid-treatment?
Yes with provider guidance. The usual move is a short washout plus a reset on titration. Coaching bridges the GI window so you don't lose the month.